Table 3.
Medications received at entry and 12-month visit
| Medications | At entry (N = 424) | 12 months (N = 383) |
|---|---|---|
| Antipsychotics | 313 (73.8%) | 261 (68.1%) |
| Typical antipsychoticsa | 174 (41.0%) | 137 (35.8%) |
| Atypical antipsychoticsa | 129 (30.4%) | 113 (29.5%) |
| Combined usea | 10 (2.4%) | 11 (2.9%) |
| Mood stabilizers (anticonvulsant) | 282 (66.5%) | 263 (68.7%) |
| Benzodiazepines | 208 (49.1%) | 176 (46.0 %) |
| Lithium | 178 (42.0%) | 155 (40.5%) |
| Anticholinergic agents | 166 (39.2%) | 129 (33.7%) |
| Antidepressants | 81 (19.1%) | 62 (16.2%) |
| Othersb | 16 (3.8%) | 19 (5.0%) |
Notes:
a
Subgroups are presented in a mutually exclusive manner;
b
propanolol and zolpidem.